Literature DB >> 33418997

Trends on Aspergillus Epidemiology-Perspectives from a National Reference Laboratory Surveillance Program.

Raquel Sabino1, Paulo Gonçalves1,2, Aryse Martins Melo1,3, Daniela Simões1, Mariana Oliveira1, Mariana Francisco1, Carla Viegas4,5,6, Dinah Carvalho7, Carlos Martins7, Teresa Ferreira8, Cristina Toscano9, Helena Simões1, Cristina Veríssimo1.   

Abstract

Identification of Aspergillus to species level is important since sibling species may display variable susceptibilities to multiple antifungal drugs and also because correct identification contributes to improve the knowledge of epidemiological studies. Two retrospective laboratory studies were conducted on Aspergillus surveillance at the Portuguese National Mycology Reference Laboratory. The first, covering the period 2017-2018, aimed to study the molecular epidemiology of 256 Aspergillus isolates obtained from patients with respiratory, subcutaneous, or systemic infections and from environmental samples. The second, using our entire collection of clinical and environmental A. fumigatus isolates (N = 337), collected between 2012 and 2019, aimed to determine the frequency of azole-resistant A. fumigatus isolates. Aspergillus fumigatus sensu stricto was the most frequent species in both clinical and environmental samples. Overall, and considering all Aspergillus sections identified, a high frequency of cryptic species was detected, based on beta-tubulin or calmodulin sequencing (37% in clinical and 51% in environmental isolates). Regarding all Fumigati isolates recovered from 2012-2019, the frequency of cryptic species was 5.3% (18/337), with the identification of A. felis (complex), A. lentulus, A. udagawae, A. hiratsukae, and A. oerlinghauensis. To determine the frequency of azole resistance of A. fumigatus, isolates were screened for azole resistance using azole-agars, and 53 possible resistant isolates were tested by the CLSI microdilution reference method. Nine A. fumigatus sensu stricto and six Fumigati cryptic isolates showed high minimal inhibitory concentrations to itraconazole, voriconazole, and/or posaconazole. Real-time PCR to detect cyp51A mutations and sequencing of cyp51A gene and its promoter were performed. The overall frequency of resistance to azoles in A. fumigatus sensu stricto was 3.0%. With this retrospective analysis, we were able to detect one azole-resistant G54R mutant A. fumigatus environmental isolate, collected in 2015. The TR34/L98H mutation, linked to environmental transmission route of azole resistance, was the most frequently detected mutation (N = 4; 1.4%). Our findings underline the demand for correct identification and susceptibility testing of Aspergillus isolates.

Entities:  

Keywords:  Aspergillus; Azole resistance mutations; cryptic species; molecular epidemiology; surveillance

Year:  2021        PMID: 33418997      PMCID: PMC7825284          DOI: 10.3390/jof7010028

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  53 in total

Review 1.  Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.

Authors:  Jacques F Meis; Anuradha Chowdhary; Johanna L Rhodes; Matthew C Fisher; Paul E Verweij
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-05       Impact factor: 6.237

2.  Is azole resistance in Aspergillus fumigatus a problem in Spain?

Authors:  Pilar Escribano; Teresa Peláez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

3.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

4.  Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis.

Authors:  Graciela Montenegro; Silvia Sánchez Puch; Virginia M Jewtuchowicz; Maria V Pinoni; Silvia Relloso; Elena Temporitti; Cristina A Iovannitti; Maria T Mujica
Journal:  J Med Microbiol       Date:  2009-03       Impact factor: 2.472

Review 5.  Exposure to Aspergillus in Home and Healthcare Facilities' Water Environments: Focus on Biofilms.

Authors:  Malcolm Richardson; Riina Rautemaa-Richardson
Journal:  Microorganisms       Date:  2019-01-05

6.  Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Authors:  Maiken Cavling Arendrup; Paul E Verweij; Johan W Mouton; Katrien Lagrou; Joseph Meletiadis
Journal:  J Antimicrob Chemother       Date:  2017-12-01       Impact factor: 5.790

7.  Aspergillus species identification in the clinical setting.

Authors:  S A Balajee; J Houbraken; P E Verweij; S-B Hong; T Yaghuchi; J Varga; R A Samson
Journal:  Stud Mycol       Date:  2007       Impact factor: 16.097

8.  Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.

Authors:  Eveline Snelders; Henrich A L van der Lee; Judith Kuijpers; Anthonius J M M Rijs; János Varga; Robert A Samson; Emilia Mellado; A Rogier T Donders; Willem J G Melchers; Paul E Verweij
Journal:  PLoS Med       Date:  2008-11-11       Impact factor: 11.069

9.  Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A. fumigatus.

Authors:  Eugénia Pinto; Carolina Monteiro; Marta Maia; Miguel A Faria; Virgínia Lopes; Catarina Lameiras; Dolores Pinheiro
Journal:  Front Microbiol       Date:  2018-07-23       Impact factor: 5.640

10.  Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.

Authors:  Pilar Escribano; Belén Rodríguez-Sánchez; Judith Díaz-García; María Teresa Martín-Gómez; Elisa Ibáñez-Martínez; María Rodríguez-Mayo; Teresa Peláez; Elia García-Gómez de la Pedrosa; Rocío Tejero-García; José María Marimón; Elena Reigadas; Antonio Rezusta; Cristina Labayru-Echeverría; Ana Pérez-Ayala; Josefina Ayats; Fernando Cobo; Carmen Pazos; Leyre López-Soria; Ana Alastruey-Izquierdo; Patricia Muñoz; Jesús Guinea
Journal:  Clin Microbiol Infect       Date:  2020-10-01       Impact factor: 8.067

View more
  3 in total

1.  Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species.

Authors:  Anna Rozaliyani; Asriyani Abdullah; Findra Setianingrum; Wellyzar Sjamsuridzal; Retno Wahyuningsih; Anom Bowolaksono; Ayu Eka Fatril; Robiatul Adawiyah; Mulyati Tugiran; Ridhawati Syam; Heri Wibowo; Chris Kosmidis; David W Denning
Journal:  J Fungi (Basel)       Date:  2022-04-16

2.  Synergy Between Pseudomonas aeruginosa Filtrates And Voriconazole Against Aspergillus fumigatus Biofilm Is Less for Mucoid Isolates From Persons With Cystic Fibrosis.

Authors:  Gabriele Sass; Julianne J Marsh; Pallabi Shrestha; Raquel Sabino; David A Stevens
Journal:  Front Cell Infect Microbiol       Date:  2022-04-14       Impact factor: 6.073

3.  Azole resistance in Aspergillus fumigatus. The first 2-year's Data from the Danish National Surveillance Study, 2018-2020.

Authors:  Malene Risum; Rasmus Krøger Hare; Jan Berg Gertsen; Lise Kristensen; Flemming Schønning Rosenvinge; Sofia Sulim; Nissrine Abou-Chakra; Jette Bangsborg; Bent Løwe Røder; Ea Sofie Marmolin; Karen Marie Thyssen Astvad; Michael Pedersen; Esad Dzajic; Steen Lomborg Andersen; Maiken Cavling Arendrup
Journal:  Mycoses       Date:  2022-02-08       Impact factor: 4.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.